Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
21 September 2018 Photo Charl Devinish
Abe Bailey Bursary victor
“I believe in self learning,” says 2018 UFS Abe Bailey victor, Nkahiseng Ralepeli.
The Abe Bailey Trust is a leadership-development opportunity that targets university students or junior lecturers who are academically strong and have shown exceptional qualities of leadership and service. Recipients of the bursary are required to have a good record of accomplishments, not only on campus but also in a broader social context, where they function as an integral piece of a select and highly-skilled group of individuals.

Ralepeli, the over-achiever

Final-year Law student, Nkahiseng Ralepeli, embodies this exact description and exemplifies the essence of distinction and merit when it comes to who he is. Ralepeli  who has represented the university at various international debate platforms, an alumni of the F1 programme to Thailand and other leadership programmes such, recently, International Youth Leadership Conference (IYLC) programme in Prague, will represent the University of the Free State (UFS) during the Abe Bailey Travel Bursary tour in the UK in December 2018. He, along with 16 other candidates from other South African tertiary institutions, will participate in the tour for its full duration and will take part in the exciting developmental programme that is planned.

With an intense but fruitful leadership-training schedule, he said he was looking forward to meeting the British members of parliament as well as other persons of stature in the British government.

Travelling: A catalyst for critical thinking

Ralepeli, who was also 3rd overall Kovsie Dux student, underlined that he truly enjoys travelling. He has subsequently mastered the art of constantly positioning himself among the best academically and socially, and this has aided his mission to trot the globe extensively, which he has been doing since his junior years.

A man of value

“I have a small yet select and impactful network of people in my life who play an influential role in reminding me during times of triumph that, while it is important to celebrate, each win is just a step towards the ultimate goal of success,” said Ralepeli. 

He emphasised the importance of the roles played by those close to him, describing them as “my double-edged sword who played a crucial role in carving out the inner Nkahiseng, who, hopefully, will do great things”. The Kovsie Dux believes that those you surround yourself with, channel the kind of energy that will either make or break you.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept